<DOC>
	<DOCNO>NCT01452438</DOCNO>
	<brief_summary>The purpose study summarize occurrence incident serious medically attend event event interest 1 year follow MenACWY-CRM vaccination administer part routine clinical care . This US FDA post-marketing commitment study open-label , descriptive , epidemiological safety surveillance study MenACWY-CRM vaccine subject 2 10 year age within large US Healthcare Maintenance Organization . The 26 event interest event commonly evaluate vaccine safety study include certain neurological , immunological , vascular , musculoskeletal hematologic disorder . All event collect retrospectively .</brief_summary>
	<brief_title>Safety Surveillance MenACWY-CRM Vaccine Children</brief_title>
	<detailed_description>This observational study , vaccine administration data collect part routine clinical care . Vaccinated subject actively recruit . Events Interest : Diabetes Mellitus , Rheumatoid arthritis , Idiopathic Thrombocytopenic Purpura , Iridocyclitis , Acute glomerulonephritis , Nephrotic syndrome , Grave 's disease , Autoimmune hemolytic anemia , Myasthenia Gravis , New onset asthma , Allergic urticaria , Anaphylaxis , Meningococcal Disease , Intentional Injury</detailed_description>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Registered HMO least 6 month prior vaccination . Between age 2 10 year ( inclusive i.e . reach 11th birthday ) time vaccination . Received MenACWYCRM vaccination vaccination period participate center .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>observational</keyword>
	<keyword>serogroup A , B , Y , W</keyword>
	<keyword>meningococcal meningitis</keyword>
	<keyword>meningococcal vaccine</keyword>
	<keyword>safety</keyword>
	<keyword>MenACYW-CRM</keyword>
	<keyword>post-marketing</keyword>
	<keyword>child</keyword>
</DOC>